Zheng, M.; Mullikin, H.; Hester, A.; Czogalla, B.; Heidegger, H.; Vilsmaier, T.; Vattai, A.; Chelariu-Raicu, A.; Jeschke, U.; Trillsch, F.;
et al. Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile. Int. J. Mol. Sci. 2020, 21, 9169.
https://doi.org/10.3390/ijms21239169
AMA Style
Zheng M, Mullikin H, Hester A, Czogalla B, Heidegger H, Vilsmaier T, Vattai A, Chelariu-Raicu A, Jeschke U, Trillsch F,
et al. Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile. International Journal of Molecular Sciences. 2020; 21(23):9169.
https://doi.org/10.3390/ijms21239169
Chicago/Turabian Style
Zheng, Mingjun, Heather Mullikin, Anna Hester, Bastian Czogalla, Helene Heidegger, Theresa Vilsmaier, Aurelia Vattai, Anca Chelariu-Raicu, Udo Jeschke, Fabian Trillsch,
and et al. 2020. "Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile" International Journal of Molecular Sciences 21, no. 23: 9169.
https://doi.org/10.3390/ijms21239169
APA Style
Zheng, M., Mullikin, H., Hester, A., Czogalla, B., Heidegger, H., Vilsmaier, T., Vattai, A., Chelariu-Raicu, A., Jeschke, U., Trillsch, F., Mahner, S., & Kaltofen, T.
(2020). Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile. International Journal of Molecular Sciences, 21(23), 9169.
https://doi.org/10.3390/ijms21239169